首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
New drugs for rare neurologicalNew drugs for rare neurological
被引:0
|
作者
:
不详
论文数:
0
引用数:
0
h-index:
0
不详
机构
:
来源
:
PROGRESS IN NEUROLOGY AND PSYCHIATRY
|
2013年
/ 17卷
/ 06期
关键词
:
D O I
:
暂无
中图分类号
:
Q189 [神经科学];
学科分类号
:
071006 ;
摘要
:
引用
收藏
页码:33 / 33
页数:1
相关论文
共 50 条
[31]
NIH pushes for rare disease drugs
Stu Hutson
论文数:
0
引用数:
0
h-index:
0
Stu Hutson
Nature Medicine,
2009,
15
: 711
-
711
[32]
NIH pushes for rare disease drugs
Hutson, Stu
论文数:
0
引用数:
0
h-index:
0
Hutson, Stu
NATURE MEDICINE,
2009,
15
(07)
: 711
-
711
[33]
The portal for rare diseases and orphan drugs
Singh, Jatinder
论文数:
0
引用数:
0
h-index:
0
机构:
Govt Med Coll, Dept Pharmacol, Amritsar, Punjab, India
Govt Med Coll, Dept Pharmacol, Amritsar, Punjab, India
Singh, Jatinder
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS,
2013,
4
(02)
: 168
-
169
[34]
FDA PROMOTES DRUGS FOR RARE DISEASES
不详
论文数:
0
引用数:
0
h-index:
0
不详
CHEMICAL & ENGINEERING NEWS,
2013,
91
(43)
: 23
-
23
[35]
DRUGS FOR RARE DISEASES - WHOSE RESPONSIBILITY
不详
论文数:
0
引用数:
0
h-index:
0
不详
LANCET,
1974,
1
(7855):
: 440
-
440
[36]
Negotiating prices of drugs for rare diseases
Henrard, Severine
论文数:
0
引用数:
0
h-index:
0
机构:
Catholic Univ Louvain, Inst Hlth & Soc IRSS, Clos Chapelle Aux Champs 30 B1-30-15, B-1200 Brussels, Belgium
Catholic Univ Louvain, Inst Hlth & Soc IRSS, Clos Chapelle Aux Champs 30 B1-30-15, B-1200 Brussels, Belgium
Henrard, Severine
Arickx, Francis
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Disabil Insurance RIZIV INAMI, Brussels, Belgium
Catholic Univ Louvain, Inst Hlth & Soc IRSS, Clos Chapelle Aux Champs 30 B1-30-15, B-1200 Brussels, Belgium
Arickx, Francis
BULLETIN OF THE WORLD HEALTH ORGANIZATION,
2016,
94
(10)
: 779
-
781
[37]
Orphan drugs and rare diseases in Andorra
Gea, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Gea, E.
Gil, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Gil, E.
Barral, N.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Barral, N.
Gonzalez, V.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Gonzalez, V.
Soler, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Soler, A.
Avellanet, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Hosp Nostra Senyora Meritxell, Escaldes, Andorra
Avellanet, M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY,
2013,
35
(05)
: 963
-
963
[38]
RARE TOXICITY WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS
KRAAG, GR
论文数:
0
引用数:
0
h-index:
0
KRAAG, GR
JOURNAL OF RHEUMATOLOGY,
1985,
12
(01)
: 1
-
3
[39]
Drugs for Heart Disease With Rare Cause
Sancar, Feyza
论文数:
0
引用数:
0
h-index:
0
Sancar, Feyza
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2019,
321
(23):
: 2274
-
2274
[40]
Big Pharma's new model in orphan drugs and rare diseases
Phillips, M. Ian
论文数:
0
引用数:
0
h-index:
0
机构:
Keck Grad Inst Appl Life Sci, Ctr Rare Dis Therapies, Claremont, CA 91711 USA
Keck Grad Inst Appl Life Sci, Ctr Rare Dis Therapies, Claremont, CA 91711 USA
Phillips, M. Ian
EXPERT OPINION ON ORPHAN DRUGS,
2013,
1
(01):
: 1
-
3
←
1
2
3
4
5
→